Effect of the free radical scavenger edaravone on peripheral nerve ischemia-reperfusion injury

Muscle and Nerve

Volumn 40, Issue 4, 2009, Pages 582-588

  Iida, Haruyasu ^a   Nagasaka, Takamura ^a   Shindo, Kazumasa ^a   Shiozawa, Zenji ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Controlled study; Edaravone; Free radical scavenger; Ischemia reperfusion injury; Oxidative stress; Peripheral nerve regeneration; Reactive oxygen species

Indexed keywords

NORPHENAZONE; REACTIVE OXYGEN METABOLITE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EDEMA; ELECTROPHYSIOLOGY; ISCHEMIA; LOW DRUG DOSE; MALE; NERVE FIBER DEGENERATION; NERVE ISCHEMIA; NERVE REGENERATION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SCIATIC NERVE; TIBIAL NERVE;

ANIMALS; ANTIPYRINE; BEHAVIOR, ANIMAL; EDEMA; ELECTROPHYSIOLOGY; FREE RADICAL SCAVENGERS; MALE; NERVE DEGENERATION; NERVE FIBERS; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 70349336762     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21388     Document Type: Article

References (43)

1. Kawamura N, Schmelzer JD, Schmeichel AM, Wang Y, Low PA. The therapeutic window of hypothermic neuroprotection in experimental ischemic neuropathy: protection in ischemic neuropathy: protection in ischemic phase and potential deterioration in later reperfusion phase. Exp Neurol 2005;195:305-312. (Pubitemid 41297783)
2. Kawamura N, Schmeichel AM, Wang Y, Schmelzer JD, Low PA. Multiple effect of hypothermia on inflammatory response following ischemia-reperfusion injury in experimental ischemic neuropathy. Exp Neurol 2006;202:487-496. (Pubitemid 44711901)
3. Mitsui Y, Schmelzer JD, Zollman PJ, Kihara M, Low PA. Hypothermic neuroprotection of peripheral nerve of rats from ischemia-reperfusion injury. Brain 1999;122:161-169. (Pubitemid 29046281)
4. Mitsui Y, Schmelzer JD, Zollman PJ, Mitsui M, Kihara M, Low PA. Hypothermic neuroprotection of peripheral nerve of rats from ischemia-reperfusion injury: intraischemic vs. reperfusion hypothermia. Brain Res 1999;827:63-69. (Pubitemid 29222905)
5. Demopoulos HB, Flamm ES, Pietronigro DD, Seligman ML. The free radical pathology and microcirculation in the major central nervous system disorders. Acta Physiol Scand 1980;492(suppl):91-119.
6. Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J. Free radicals in cerebral ischemia. Stroke 1978;9:445-447.
7. Gray C, Nukada H, Jackson DM, McMorran PD, Wu A, Ma F. Neuroprotective effect of nitrone radical scavenger S-PBN on reperfusion nerve injury in rats. Brain Res 2003;982:179-185. (Pubitemid 37281415)
8. Mitsui Y, Schmelzer JD, Zollman PJ, Mitsui M, Tritschler HJ, Low PA. Alpha-lipoic acid provides neuroprotection from ischemia-reperfusion injury of peripheral nerve. J Neurol Sci 1999;163:11-16. (Pubitemid 29155409)
9. Iida H, Schmelzer JD, Schmeichel AM, Wang Y, Low PA. Peripheral nerve ischemia: reperfusion injury and nerve regeneration. Exp Neurol 2003;184:997-1002. (Pubitemid 38182829)
10. Iida H, Schmeichel AM, Wang Y, Schmelzer JD, Low PA. Schwann cell is a target in ischemia-reperfusion injury to peripheral nerve. Muscle Nerve 2004;30:761-766. (Pubitemid 39601292)
11. Ono S, Okazaki K, Sakurai M, Inoue Y. Density functional study of the radical reactions of 3-methyl-1-phenyl-2pyrazolin- 5-one (MCI-186): implication for the biological function of MCI-186 as a highly potent antioxidative radical scavenger. J Phys Chem A Mol Spectrosc Kinet Environ Gen Theory 1997;101:3769-3775. (Pubitemid 127598730)
12. Watanabe K, Watanabe K, Kuwahara T, Yamamoto Y. Free radical-induced oxidation products of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186). J Jpn Oil Chem Soc 1997;46:797-801.
13. Watanabe K, Watanabe K, Hayase T. Radical scavenging mechanism of MCI-186 [in Japanese]. Yakuri to Chiryo 1997;25(suppl):1699-1707.
14. Yamamoto T, Yuki S, Watanabe T, Mitsuka M, Saito K, Kogure K. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res 1997;762:240-242. (Pubitemid 27315958)
15. Watanabe T, Yuki S, Egawa M, Nishi H. Protective effects of MCL-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 1994;268:1597-1604. (Pubitemid 24100383)
16. Watanabe T, Morita I, Nishi H, Murota S. Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostagland Leukot Essent Fatty Acids 1988;33:81-87. (Pubitemid 18175123)
17. Abe K, Yuki S, Kogure K. Strong attenuation of ischemic and post ischemic brain edema in rats by a novel free radical scavenger. Stroke 1988;19:480-485. (Pubitemid 18121101)
18. Nishi H, Watanabe T, Sakurai H, Yuki S, Ishibashi A. Effect of MCL-186 on brain edema in rats. Stroke 1989;20:1236-1240. (Pubitemid 19226920)
19. Takamatsu Y, Yuki S, Watanabe T. Studies on the concentrations of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) in a rat model of MCA occlusion and reperfusion model. Yakuri to Chiryo 1997;25(suppl):1785-1791. (Pubitemid 28030798)
20. Yamamoto Y, Kuwahara T, Watanabe K, Watanabe K. Antioxidation activity of 3-methyl-1-phenyl-pyrazolin-5-one. Redox Rep 1996;2:333-336.
21. Kawai H, Kanai H, Suga M, Yuki S, Watanabe T, Saito K. Effect of a novel free radical scavenger, MCL-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J Pharmacol Exp Ther 1997;281:921-927. (Pubitemid 27203828)
22. Mizuno A, Umemura K, Nakashima M. Inhibitory effect of MCL-186, a free radical scavenger, on cerebral ischemia following rat middle cerebral artery occlusion. Gen Pharmacol 1998;30:575-578. (Pubitemid 28102837)
23. Takahashi G, Sakurai M, Abe K, Itoyama Y, Tabayashi K. MCL-186 prevents spinal cord damage and affects enzyme levels of nitric oxide synthase and Cu/Zn superoxide dismutase after transient ischemia in rabbits. J Thorac Cardiovasc Surg 2003;126:1461-1466. (Pubitemid 37449174)
24. Rajesh KG, Sasaguri S, Suzuki R, Maeda H. Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression. Am J Physiol Heart Circ Physiol 2003;285:2171-2178. (Pubitemid 37305962)
25. Doi K, Suzuki Y, Nakao A, Fujita T, Noiri E. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int 2004;65:1714-1723. (Pubitemid 38591019)
26. Ninomiya M, Shimada M, Harada N, Soejima Y, Suehiro T, Maehara Y. The hydroxyl radical scavenger MCI-186 protects the liver from experimental cold ischemia-reperfusion injury. Br J Surg 2004;91:184-190. (Pubitemid 38233963)
27. Edaravone Acute Brain Infarction Study Group (Otomo E, chair). Effect of a novel free radical scavenger, edaravone (MCL-186), on acute brain infarction. Cerebrovasc Dis 2003;15:222-229.
28. Iida H, Schmeichel AM, Wang Y, Schmelzer JD, Low PA. Orchestration of the inflammatory response in ischemia-reperfusion injury. J Peripher Nerv Syst 2007;12:131-138. (Pubitemid 46906335)
29. Wang Y, Schmelzer JD, Schmeichel AM, Iida H, Low PA. Ischemia-reperfusion injury of peripheral nerve in experimental diabetic neuropathy. J Neurol Sci 2004;227:101-107. (Pubitemid 39491132)
30. Wang Y, Schmeichel AM, Iida H, Schmelzer JD, Low PA. Ischemia-reperfusion injury causes oxidative stress and apoptosis of Schwann cell in acute and chronic experimental diabetic neuropathy. Antioxid Redox Signal 2005;7:1513-1520. (Pubitemid 41767987)
31. Wang Y, Schmeichel AM, Iida H, Schmelzer JD, Low PA. Enhanced inflammatory response via activation of NF-κ B in acute experimental diabetic neuropathy subjected to ischemia-reperfusion injury. J Neurol Sci 2006;247:47-52. (Pubitemid 44164297)
32. Schmelzer JD, Zochodne DW, Low PA. Ischemic and reperfusion injury of rat peripheral nerve. Proc Natl Acad Sci USA 1989;86:1639-1642. (Pubitemid 19078958)
33. Kihara M, Zollman PJ, Schmelzer JD, Low PA. The influence of dose of microspheres on nerve blood flow, electrophysiology and fiber degeneration of rat peripheral nerve. Muscle Nerve 1993;16:1383-1389. (Pubitemid 23351092)
34. Nagamatsu M, Schmelzer JD, Zollman PJ, Smithson IL, Nickander KK, Low PA. Ischemic reperfusion causes lipid peroxidation and fiber degeneration. Muscle Nerve 1996;19:37-47. (Pubitemid 26010949)
35. Nukada H, Dyck PJ. Microsphere embolization of nerve capillaries and fiber degeneration. Am J Pathol 1984;115:275-287. (Pubitemid 14145909)
36. Redford EJ, Kapoor R, Smith KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997;120:2149-2157. (Pubitemid 28014591)
37. Eckersley L, Ansselin AD, Tomlinson DR. Effects of experimental diabetes on axonal and Schwann cell changes in sciatic nerve isografts. Mol Brain Res 2001;92:128-137. (Pubitemid 32718712)
38. Levy D, Hoke A, Zochodne DW. Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain. Neurosci Lett 1999;260:207-209. (Pubitemid 29089197)
39. Levy D, Kubes P, Zochodne DW. Delayed peripheral degeneration, regeneration, and pain in mice lacking inducible nitric oxide synthase. J Neuropathol Exp Neurol 2001;60:411-421. (Pubitemid 32467098)
40. Zochodne DW, Levy D, Zwiers H, Sun H, Rubin E, Cheng C, et al. Evidence for nitric oxide and nitric oxide synthase activity in proximal stumps of transected peripheral nerves. Neuroscience 1999;91:1515-1527. (Pubitemid 29234277)
41. Dalgard DW, Koka M, Miura M, Tamura S. Twenty six-week intravenous toxicity study of MCI-186 in beagle dogs with a recovery period of 5 weeks. Yakuri to Chiryo 1997;25(suppl):1589-1614.
42. Yoshida H, Kwon AH, Kaibori M, Tsuji K, Habara K, Yamada M, et al. Edaravone prevents iNOS expression by inhibiting its promoter transactivation and mRNA stability in cytokine-stimulated hepatocytes. Nitric Oxide 2007;18:105-112.
43. Noor JI, Ikeda T, Mishima K, Aoo N, Ohta S, Egashira N, et al. Short-term administration of a new free radical scavenger, edaravone, is more effective than its long-term administration for the treatment of neonatal hypoxic-ischemic encephalopathy. Stroke 2005;36:2468-2474. (Pubitemid 41566979)